Literature DB >> 16931942

Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.

Catharina E A Lindenburg1, Anneke Krol, Colette Smit, Marcel C A Buster, Roel A Coutinho, Maria Prins.   

Abstract

OBJECTIVE: To study temporal changes in HIV incidence, HIV transmission routes, and both injecting and sexual risk behaviour in the open Amsterdam Cohort Study (ACS) among drug users. Initiated in 1985, the ACS enables us to study changes in trends since HAART became widespread in 1996.
METHODS: Person-time techniques were used to study the trend in HIV incidence among HIV-negative drug users. HIV transmission routes were determined using detailed standardised questionnaires. Trends in injecting and sexual risk behaviours were evaluated with a logistic regression model adjusted for correlations between visits of the same individual.
RESULTS: The 1315 HIV-negative individuals, of whom 93 seroconverted for HIV, yielded 6970 HIV-negative person-years of follow-up. The HIV incidence was seven per 100 person-years in 1986 and varied between 0 and 0.5 per 100 person-years after 1999. The odds ratio was 15.6 (95% confidence interval, 2.6-94.6) for HIV transmission through unprotected heterosexual contact versus injecting after 1996 compared with the period before. Reports of both injecting and borrowing needles significantly declined over the period 1985-2004. Reports of sexual risk behaviour and sexually transmitted infections at follow-up visits decreased before 1996, but not after 1996.
CONCLUSION: The HIV incidence among drug users in the ACS has declined since 1985. Accompanied by a reduction in injecting drug use and needle sharing, this decline occurred despite continued sexual risk behaviour. At present, new HIV seroconversions are related mainly to unprotected heterosexual contacts. Therefore, HIV prevention programmes for drug users should pay specific attention to the importance of safe sex practices.

Entities:  

Mesh:

Year:  2006        PMID: 16931942     DOI: 10.1097/01.aids.0000242824.59377.53

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

1.  Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Holly Hagan; David C Perlman; Salaam Semaan
Journal:  Am J Public Health       Date:  2011-05-12       Impact factor: 9.308

2.  The association between social marginalisation and the injecting of alcohol amongst IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus
Journal:  Int J Drug Policy       Date:  2011-07-20

3.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

4.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

Authors:  Charlotte H S B van den Berg; Colette Smit; Margreet Bakker; Ronald B Geskus; Ben Berkhout; Suzanne Jurriaans; Roel A Coutinho; Katja C Wolthers; Maria Prins
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

5.  Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.

Authors:  Tsung-chieh Fu; Ryan P Westergaard; Bryan Lau; David D Celentano; David Vlahov; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2012-11-28       Impact factor: 4.177

6.  Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois.

Authors:  Dezheng Huo; Lawrence J Ouellet
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

7.  Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting.

Authors:  M Rondy; L Wiessing; S J Hutchinson; C Matheï; F Mathis; V Mravcik; L Norden; M Rosińska; O Scutelniciuc; B Suligoi; F Vallejo; M VAN Veen; M Kretzschmar
Journal:  Epidemiol Infect       Date:  2012-05-17       Impact factor: 4.434

8.  Drug users in Amsterdam: are they still at risk for HIV?

Authors:  Nienke van der Knaap; Bart P X Grady; Maarten F Schim van der Loeff; Titia Heijman; Arjen Speksnijder; Ronald Geskus; Maria Prins
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

9.  Changing risk behaviours and the HIV epidemic: a mathematical analysis in the context of treatment as prevention.

Authors:  Bojan Ramadanovic; Krisztina Vasarhelyi; Ali Nadaf; Ralf W Wittenberg; Julio S G Montaner; Evan Wood; Alexander R Rutherford
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.